Literature DB >> 20207227

Embryonic MGE precursor cells grafted into adult rat striatum integrate and ameliorate motor symptoms in 6-OHDA-lesioned rats.

Verónica Martínez-Cerdeño1, Stephen C Noctor, Ana Espinosa, Jeanelle Ariza, Philip Parker, Samantha Orasji, Marcel M Daadi, Krystof Bankiewicz, Arturo Alvarez-Buylla, Arnold R Kriegstein.   

Abstract

We investigated a strategy to ameliorate the motor symptoms of rats that received 6-hydroxydopamine (6-OHDA) lesions, a rodent model of Parkinson's disease, through transplantation of embryonic medial ganglionic eminence (MGE) cells into the striatum. During brain development, embryonic MGE cells migrate into the striatum and neocortex where they mature into GABAergic interneurons and play a key role in establishing the balance between excitation and inhibition. Unlike most other embryonic neurons, MGE cells retain the capacity for migration and integration when transplanted into the postnatal and adult brain. We performed MGE cell transplantation into the basal ganglia of control and 6-OHDA-lesioned rats. Transplanted MGE cells survived, differentiated into GABA(+) neurons, integrated into host circuitry, and modified motor behavior in both lesioned and control rats. Our data suggest that MGE cell transplantation into the striatum is a promising approach to investigate the potential benefits of remodeling basal ganglia circuitry in neurodegenerative diseases. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20207227      PMCID: PMC4075336          DOI: 10.1016/j.stem.2010.01.004

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  54 in total

Review 1.  Functional diversity and specificity of neostriatal interneurons.

Authors:  James M Tepper; J Paul Bolam
Journal:  Curr Opin Neurobiol       Date:  2004-12       Impact factor: 6.627

2.  The temporal and spatial origins of cortical interneurons predict their physiological subtype.

Authors:  Simon J B Butt; Marc Fuccillo; Susana Nery; Steven Noctor; Arnold Kriegstein; Joshua G Corbin; Gord Fishell
Journal:  Neuron       Date:  2005-11-23       Impact factor: 17.173

3.  Cortical inhibition modified by embryonic neural precursors grafted into the postnatal brain.

Authors:  Manuel Alvarez-Dolado; Maria Elisa Calcagnotto; Kameel M Karkar; Derek G Southwell; Dorothy M Jones-Davis; Rosanne C Estrada; John L R Rubenstein; Arturo Alvarez-Buylla; Scott C Baraban
Journal:  J Neurosci       Date:  2006-07-12       Impact factor: 6.167

Review 4.  Circuits and circuit disorders of the basal ganglia.

Authors:  Mahlon R DeLong; Thomas Wichmann
Journal:  Arch Neurol       Date:  2007-01

5.  Enhanced expression of glutamate decarboxylase 65 improves symptoms of rat parkinsonian models.

Authors:  B Lee; H Lee; Y R Nam; J H Oh; Y H Cho; J W Chang
Journal:  Gene Ther       Date:  2005-08       Impact factor: 5.250

6.  Differential expression of the GABA transporters GAT-1 and GAT-3 in brains of rats, cats, monkeys and humans.

Authors:  David V Pow; Robert K P Sullivan; Susan M Williams; Heather L Scott; Peter R Dodd; David Finkelstein
Journal:  Cell Tissue Res       Date:  2005-04-09       Impact factor: 5.249

7.  Cortical inputs and GABA interneurons imbalance projection neurons in the striatum of parkinsonian rats.

Authors:  Nicolas Mallet; Bérangère Ballion; Catherine Le Moine; François Gonon
Journal:  J Neurosci       Date:  2006-04-05       Impact factor: 6.167

8.  Increased cell suspension concentration augments the survival rate of grafted tyrosine hydroxylase immunoreactive neurons.

Authors:  Brian T Terpstra; Timothy J Collier; Deanna M Marchionini; Nathan D Levine; Katrina L Paumier; Caryl E Sortwell
Journal:  J Neurosci Methods       Date:  2007-07-01       Impact factor: 2.390

9.  Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial.

Authors:  Michael G Kaplitt; Andrew Feigin; Chengke Tang; Helen L Fitzsimons; Paul Mattis; Patricia A Lawlor; Ross J Bland; Deborah Young; Kristin Strybing; David Eidelberg; Matthew J During
Journal:  Lancet       Date:  2007-06-23       Impact factor: 79.321

Review 10.  The etiopathogenesis of Parkinson disease and suggestions for future research. Part I.

Authors:  Irene Litvan; Glenda Halliday; Mark Hallett; Christopher G Goetz; Walter Rocca; Charles Duyckaerts; Yoav Ben-Shlomo; Dennis W Dickson; Anthony E Lang; Marie-Francoise Chesselet; William J Langston; Donato A Di Monte; Thomas Gasser; Theo Hagg; John Hardy; Peter Jenner; Eldad Melamed; Richard H Myers; Davis Parker; Donald L Price
Journal:  J Neuropathol Exp Neurol       Date:  2007-04       Impact factor: 3.685

View more
  56 in total

Review 1.  Impact of induced pluripotent stem cells on the study of central nervous system disease.

Authors:  Paige E Cundiff; Stewart A Anderson
Journal:  Curr Opin Genet Dev       Date:  2011-01-27       Impact factor: 5.578

Review 2.  The contribution of GABAergic dysfunction to neurodevelopmental disorders.

Authors:  Kartik Ramamoorthi; Yingxi Lin
Journal:  Trends Mol Med       Date:  2011-04-21       Impact factor: 11.951

Review 3.  Potential of GABA-ergic cell therapy for schizophrenia, neuropathic pain, and Alzheimer's and Parkinson's diseases.

Authors:  Ashok K Shetty; Adrian Bates
Journal:  Brain Res       Date:  2015-09-28       Impact factor: 3.252

4.  Spatial and temporal bias in the mitotic origins of somatostatin- and parvalbumin-expressing interneuron subgroups and the chandelier subtype in the medial ganglionic eminence.

Authors:  Melis Inan; Jelle Welagen; Stewart A Anderson
Journal:  Cereb Cortex       Date:  2011-06-21       Impact factor: 5.357

5.  Interneuron Origins in the Embryonic Porcine Medial Ganglionic Eminence.

Authors:  Mariana L Casalia; Tina Li; Harrison Ramsay; Pablo J Ross; Mercedes F Paredes; Scott C Baraban
Journal:  J Neurosci       Date:  2021-02-26       Impact factor: 6.167

6.  In vivo reprogramming of circuit connectivity in postmitotic neocortical neurons.

Authors:  Andres De la Rossa; Camilla Bellone; Bruno Golding; Ilaria Vitali; Jonathan Moss; Nicolas Toni; Christian Lüscher; Denis Jabaudon
Journal:  Nat Neurosci       Date:  2013-01-06       Impact factor: 24.884

7.  Engraftment of human nasal olfactory stem cells restores neuroplasticity in mice with hippocampal lesions.

Authors:  Emmanuel Nivet; Michel Vignes; Stéphane D Girard; Caroline Pierrisnard; Nathalie Baril; Arnaud Devèze; Jacques Magnan; Fabien Lanté; Michel Khrestchatisky; François Féron; François S Roman
Journal:  J Clin Invest       Date:  2011-06-13       Impact factor: 14.808

Review 8.  Promoting Brain Repair and Regeneration After Stroke: a Plea for Cell-Based Therapies.

Authors:  Ania Dabrowski; Thomas J Robinson; Ryan J Felling
Journal:  Curr Neurol Neurosci Rep       Date:  2019-02-02       Impact factor: 5.081

Review 9.  GABAergic interneuron transplants to study development and treat disease.

Authors:  Jennifer A Tyson; Stewart A Anderson
Journal:  Trends Neurosci       Date:  2014-02-07       Impact factor: 13.837

10.  Olig1 function is required to repress dlx1/2 and interneuron production in Mammalian brain.

Authors:  John C Silbereis; Hiroko Nobuta; Hui-Hsin Tsai; Vivi M Heine; Gabriel L McKinsey; Dimphna H Meijer; Mackenzie A Howard; Magda A Petryniak; Gregory B Potter; John A Alberta; Scott C Baraban; Charles D Stiles; John L R Rubenstein; David H Rowitch
Journal:  Neuron       Date:  2014-02-05       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.